177 related articles for article (PubMed ID: 34695226)
1. Association of healthy lifestyle and all-cause mortality according to medication burden.
Kelly NA; Soroka O; Onyebeke C; Pinheiro LC; Banerjee S; Safford MM; Goyal P
J Am Geriatr Soc; 2022 Feb; 70(2):415-428. PubMed ID: 34695226
[TBL] [Abstract][Full Text] [Related]
2. Association of Healthy Lifestyle and Incident Polypharmacy.
Koren MJ; Kelly NA; Lau JD; Jonas CK; Pinheiro LC; Banerjee S; Safford MM; Goyal P
Am J Med; 2024 May; 137(5):433-441.e2. PubMed ID: 38176533
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.
Whitney DG; Schmidt M; Haapala H
J Manag Care Spec Pharm; 2021 Jan; 27(1):51-63. PubMed ID: 33377441
[No Abstract] [Full Text] [Related]
4. A healthy lifestyle attenuates the effect of polypharmacy on total and cardiovascular mortality: a national prospective cohort study.
Martinez-Gomez D; Guallar-Castillon P; Higueras-Fresnillo S; Banegas JR; Sadarangani KP; Rodriguez-Artalejo F
Sci Rep; 2018 Aug; 8(1):12615. PubMed ID: 30135569
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from The English Longitudinal Study of Ageing (ELSA).
Slater N; White S; Venables R; Frisher M
BMJ Open; 2018 Mar; 8(3):e020270. PubMed ID: 29540422
[TBL] [Abstract][Full Text] [Related]
6. The association of degree of polypharmacy before and after among hospitalised internal medicine patients and clinical outcomes: a retrospective, population-based cohort study.
Jonsdottir F; Blondal AB; Gudmundsson A; Bates I; Stevenson JM; Sigurdsson MI
BMJ Open; 2024 Mar; 14(3):e078890. PubMed ID: 38548367
[TBL] [Abstract][Full Text] [Related]
7. The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK Biobank cohort.
Foster HME; Celis-Morales CA; Nicholl BI; Petermann-Rocha F; Pell JP; Gill JMR; O'Donnell CA; Mair FS
Lancet Public Health; 2018 Dec; 3(12):e576-e585. PubMed ID: 30467019
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.
Schöttker B; Saum KU; Muhlack DC; Hoppe LK; Holleczek B; Brenner H
Eur J Clin Pharmacol; 2017 Aug; 73(8):1041-1048. PubMed ID: 28540438
[TBL] [Abstract][Full Text] [Related]
9. Association of Lifestyle Factors and Antihypertensive Medication Use With Risk of All-Cause and Cause-Specific Mortality Among Adults With Hypertension in China.
Lu Q; Zhang Y; Geng T; Yang K; Guo K; Min X; He M; Guo H; Zhang X; Yang H; Wu T; Pan A; Liu G
JAMA Netw Open; 2022 Feb; 5(2):e2146118. PubMed ID: 35103793
[TBL] [Abstract][Full Text] [Related]
10. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
Porter B; Arthur A; Savva GM
BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
[TBL] [Abstract][Full Text] [Related]
11. Association between a lifestyle score and all-cause mortality: a prospective analysis of the Chilean National Health Survey 2009-2010.
Petermann-Rocha F; Diaz-Toro F; Troncoso-Pantoja C; Martínez-Sanguinetti MA; Leiva-Ordoñez AM; Nazar G; Concha-Cisternas Y; Díaz Martínez X; Lanuza F; Carrasco-Marín F; Martorell M; Ramírez-Alarcón K; Labraña AM; Parra-Soto S; Villagran M; Lasserre-Laso N; Cigarroa I; Mardones L; Vásquez-Gómez J; Celis-Morales CA;
Public Health Nutr; 2023 Dec; 27(1):e9. PubMed ID: 38053402
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis.
Bhagavathula AS; Vidyasagar K; Chhabra M; Rashid M; Sharma R; Bandari DK; Fialova D
Front Pharmacol; 2021; 12():685518. PubMed ID: 34093207
[No Abstract] [Full Text] [Related]
13. Combined associations of body mass index and adherence to a Mediterranean-like diet with all-cause and cardiovascular mortality: A cohort study.
Michaëlsson K; Baron JA; Byberg L; Höijer J; Larsson SC; Svennblad B; Melhus H; Wolk A; Warensjö Lemming E
PLoS Med; 2020 Sep; 17(9):e1003331. PubMed ID: 32941436
[TBL] [Abstract][Full Text] [Related]
14. Lifestyle-Related Factors and Total Mortality in a Mediterranean Prospective Cohort.
Ruiz-Estigarribia L; Martínez-González MÁ; Díaz-Gutiérrez J; Gea A; Rico-Campà A; Bes-Rastrollo M
Am J Prev Med; 2020 Aug; 59(2):e59-e67. PubMed ID: 32430220
[TBL] [Abstract][Full Text] [Related]
15. Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial.
Wu Y; Zhu W; He X; Xue R; Liang W; Wei F; Wu Z; Zhou Y; Wu D; He J; Dong Y; Liu C
Br J Gen Pract; 2021 Jan; 71(702):e62-e70. PubMed ID: 33257457
[TBL] [Abstract][Full Text] [Related]
16. Association of a healthy lifestyle with mortality in older people.
Robb C; Carr PR; Ball J; Owen A; Beilin LJ; Newman AB; Nelson MR; Reid CM; Orchard SG; Neumann JT; Tonkin AM; Wolfe R; McNeil JJ
BMC Geriatr; 2023 Oct; 23(1):646. PubMed ID: 37821846
[TBL] [Abstract][Full Text] [Related]
17. Frailty modifies the effect of polypharmacy and multimorbidity on the risk of death among nursing home residents: Results from the SHELTER study.
Zazzara MB; Villani ER; Palmer K; Fialova D; Corsonello A; Soraci L; Fusco D; Cipriani MC; Denkinger M; Onder G; Liperoti R
Front Med (Lausanne); 2023; 10():1091246. PubMed ID: 36817789
[TBL] [Abstract][Full Text] [Related]
18. Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial.
Lockery JE; Ernst ME; Broder JC; Orchard SG; Murray A; Nelson MR; Stocks NP; Wolfe R; Reid CM; Liew D; Woods RL;
Pharmacotherapy; 2020 Oct; 40(10):1042-1053. PubMed ID: 33078479
[TBL] [Abstract][Full Text] [Related]
19. Association of Adherence to Healthy Lifestyle Recommendations With All-Cause and Cause-Specific Mortality Among Former Smokers.
Inoue-Choi M; Ramirez Y; Fukunaga A; Matthews CE; Freedman ND
JAMA Netw Open; 2022 Sep; 5(9):e2232778. PubMed ID: 36136331
[TBL] [Abstract][Full Text] [Related]
20. Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the REasons for Geographic and Racial Differences in Stroke Study).
Booth JN; Levitan EB; Brown TM; Farkouh ME; Safford MM; Muntner P
Am J Cardiol; 2014 Jun; 113(12):1933-40. PubMed ID: 24793668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
